Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

Cancer

Volumn 75, Issue 2, 1995, Pages 530-538

  Peller, Paul A ^a   Young, Donn C ^a   Marmaduke, David P ^a   Marsh, William L ^a   Badalament, Robert A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

prostate cancer; prostate specific antigen; prostate specific antigen density; radical prostatectomy; sextant biopsy; staging; tumor volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; DIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM;

AGE FACTORS; AGED; BIOPSY; HUMAN; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; PLOIDIES; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RACIAL STOCKS; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE FIXATION;

EID: 0028850949     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950115)75:2<530::AID-CNCR2820750216>3.0.CO;2-Y     Document Type: Article

References (29)

1. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread
2. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer
3. The accuracy of CT in the staging of carcinoma of the prostate
4. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
5. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
6. Systematic sextant biopsies in 651 patients referred for prostate evaluation
7. Advantage of systematic random ultrasound‐guided biopsies, measurement of serum prostate specific antigen level and determination of prostate volume in the early diagnosis of prostate cancer
8. Predictive value of contralateral biopsies in unilaterally palpable prostate cancer
9. Histologic grade, clinical stage and patient age in prostate cancer
10. Technical and statistical improvements for flow cytometric DNA analysis of paraffin‐embedded tissue
11. DNA ploidy and prostate specific antigen as prognostic factors in clinically resectable prostate cancer
12. Nerve‐sparing radical prostatectomy: evaluation of results after 250 patients
13. Positive surgical margins at radical prostatectomy: importance of the apical dissection
14. Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease‐free survival after radical prostatectomy
15. Incidence of surgical margin involvement in various forms of radical prostatectomy
16. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer
17. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
18. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age‐referenced PSA, PSA density and PSA change
19. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
20. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer
21. Is tumor volume an independent predictor of progression following radical prostatectomy?: a multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup
22. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer
23. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens
24. Detection of clinically significant prostate cancer by transrectal ultrasound‐guided systematic biopsies
25. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate in radical prostatectomy treated patients
26. Morphometric and clinical studies on 68 consecutive radical prostatectomies
27. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia